-
1
المؤلفون: Barjesteh van Waalwijk van Doorn-Khosrovani, Sahar, Taskén, Kjetil, F Haj Mohammad, Soemeya, Fagereng, Gro Live, Sørum Falk, Ragnhild, Helland, Åslaug, Jalkanen, Katriina, Edsjö, Anders, Russnes, Hege G, Steen Carlsson, Katarina, Ryll, Bettina, Lassen, Ulrik, Hallersjö Hult, Ebba, Lugowska, Iwona, Blay, Jean-Yves, Verlingue, Loic, Abel, Edvard, Lowery, Maeve A, Krebs, Matthew G, Staal Rohrberg, Kristoffer, Ojamaa, Kristiina, Oliveira, Julio, Verheul, Henk M W, Voest, Emile E, Gelderblom, Hans
المساهمون: PRIME-ROSE Consortium and the PCM4EU Consortium
المصدر: Acta Oncologica. 63:385-391
وصف الملف: electronic
-
2
المؤلفون: Taskén, Kjetil, Sørum Falk, Ragnhild, Helland, Åslaug, Fagereng, Gro Live, Abel, Edvard, Baltruskeviciene, Edita, Steen Carlsson, Katarina, Jalkanen, Katriina, Krebs, Matthew G, Lassen, Ulrik, Lowery, Maeve A, Ojamaa, Kristiina, Oliveira, Julio, Verlingue, Loic, Staal Rohrberg, Kristoffer, Ryll, Bettina, Barjesteh van Waalwijk van Doorn-Khosrovani, Sahar, Voest, Emile Eugene, Gelderblom, Hans, Verheul, Henk M W
المصدر: Journal of Clinical Oncology. 42(16)
-
3دورية أكاديمية
المؤلفون: Verkerk, Karlijn, Geurts, Birgit S., Zeverijn, Laurien J., van der Noort, Vincent, Verheul, Henk M.W., Haanen, John B.A.G., van der Veldt, Astrid A.M., Eskens, Ferry A.L.M., Aarts, Maureen J.B., van Herpen, Carla M.L., Jalving, Mathilde, Gietema, Jourik A., Devriese, Lot A., Labots, Mariette, Barjesteh van Waalwijk van Doorn-Khosrovani, Sahar, Smit, Egbert F., Bloemendal, Haiko J.
المصدر: In The Lancet Regional Health - Europe April 2024 39
-
4دورية أكاديمية
المؤلفون: Billingham, Lucinda, Brown, Lynn, Framke, Theodor, Greystoke, Alastair, Hovig, Eivind, Mathur, Siddhartha, Page, Philippe, Pean, Elias, Barjesteh van Waalwijk van Doorn-Khosrovani, Sahar, Vonk, Richardus, Wissink, Sacha, Zander, Hilke, Plummer, Ruth
المصدر: In Cancer Treatment Reviews February 2024 123
-
5دورية أكاديمية
المؤلفون: Barjesteh van Waalwijk van Doorn-Khosrovani, Sahar, Spensberger, Dominik, de Knegt, Yvonne, Tang, Michelle, Löwenberg, Bob, Delwel, RuudAff1, ID1208588_cor6
المصدر: Oncogene. 24(25):4129-4137
-
6دورية أكاديمية
المؤلفون: Barjesteh van Waalwijk van Doorn-Khosrovani, Sahar, Timmers, Lonneke, Pisters-van Roy, Anke, Gijzen, Joël, Blijlevens, Nicole M.A., Bloemendal, Haiko
المصدر: Journal of Market Access & Health Policy; Dec 2021, Vol. 9 Issue 1, p1-4, 4p
مصطلحات موضوعية: TREATMENT effectiveness, DRUG efficacy, OFF-label use (Drugs), REVENUE accounting, FINANCIAL risk
-
7دورية أكاديمية
المؤلفون: Barjesteh van Waalwijk van Doorn-Khosrovani, Sahar, Erpelinck, Claudia, van Putten, WimL.J., Valk, PeterJ.M., van der Poel-van de Luytgaarde, Sonja, Hack, Ronald, Slater, Rosalyn, Smit, ElisabethM.E., Beverloo, H. Berna, Verhoef, Gregor, Verdonck, Leo F., Ossenkoppele, Gert J., Sonneveld, Pieter, de Greef, Georgine E., Löwenberg, Bob, Delwel, Ruud *
المصدر: In Blood 1 February 2003 101(3):837-845
-
8دورية
المؤلفون: Barjesteh van Waalwijk van Doorn-Khosrovani, Sahar, Erpelinck, Claudia, van Putten, WimL.J., Valk, PeterJ.M., van der Poel-van de Luytgaarde, Sonja, Hack, Ronald, Slater, Rosalyn, Smit, ElisabethM.E., Beverloo, H. Berna, Verhoef, Gregor, Verdonck, Leo F., Ossenkoppele, Gert J., Sonneveld, Pieter, de Greef, Georgine E., Löwenberg, Bob, Delwel, Ruud
المصدر: Blood; February 2003, Vol. 101 Issue: 3 p837-845, 9p
-
9دورية أكاديمية
المؤلفون: Barjesteh van Waalwijk van Doorn-Khosrovani S; Department of Medical Oncology, Leiden University Medical Centre, Leiden, the Netherlands; Medical Department, CZ Health Insurance, Tilburg, the Netherlands. Electronic address: sahar.van.waalwijk@cz.nl., Kholmanskikh Van Criekingen O; Belgian Federal Agency for Medicinal and Health Products (FAMHP), Brussels, Belgium., Koole S; Medical Advisory Department, Zilveren Kruis, Zeist, the Netherlands., Thomas DM; Centre for Molecular Oncology, University of New South Wales, Sydney, NSW, Australia., Gelderblom H; Department of Medical Oncology, Leiden University Medical Centre, Leiden, the Netherlands.
المصدر: Cancer cell [Cancer Cell] 2024 Jun 10; Vol. 42 (6), pp. 923-929.
نوع المنشور: Journal Article; Review
بيانات الدورية: Publisher: Cell Press Country of Publication: United States NLM ID: 101130617 Publication Model: Print Cited Medium: Internet ISSN: 1878-3686 (Electronic) Linking ISSN: 15356108 NLM ISO Abbreviation: Cancer Cell Subsets: MEDLINE
مواضيع طبية MeSH: Drug Development*/methods , Precision Medicine*/methods , Poly(ADP-ribose) Polymerase Inhibitors*/therapeutic use , Biomarkers, Tumor*, Humans ; Neoplasms/drug therapy
-
10دورية أكاديمية
المؤلفون: Taskén K; Institute for Cancer Research, Oslo University Hospital and Institute of Clinical Medicine, University of Oslo, Oslo, Norway. kjetil.tasken@medisin.uio.no., F Haj Mohammad S; Department of Medical Oncology, Leiden University Medical Centre, Leiden, The Netherlands. s.f.haj_mohammad@lumc.nl., Fagereng GL; Institute for Cancer Research, Oslo University Hospital and Institute of Clinical Medicine, University of Oslo, Oslo, Norway. gfageren@ous-hf.no., Sørum Falk R; Oslo Centre for Biostatistics and Epidemiology, Oslo University Hospital, Oslo, Norway. rs@ous-hf.no., Helland Å; Institute for Cancer Research, Oslo University Hospital and Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway. aslaug.helland@medisin.uio.no., Barjesteh van Waalwijk van Doorn-Khosrovani S; Department of Medical Oncology, Leiden University Medical Centre, Leiden, The Netherlands; CZ Health Insurance, Tilburg, The Netherlands. sahar.van.waalwijk@cz.nl., Steen Carlsson K; Swedish Institute for Health Economics, Lund, Sweden. katarina.steen_carlsson@ihe.se., Ryll B; Stockholm School of Economics Institute for Research, Stockholm, Sweden. Bettina.Ryll@hhs.se., Jalkanen K; Clinical Trial Unit, Comprehensive Cancer Centre, Helsinki University Hospital, Helsinki, Finland. katriina.jalkanen@hus.fi., Edsjö A; Department of Clinical Genetics, Pathology and Molecular Diagnostics, Region Skåne, Malmö, Sweden. anders.edsjo@skane.se., Russnes HG; Institute for Cancer Research, Oslo University Hospital and Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Department of Pathology, Oslo University Hospital, Oslo, Norway. h.e.g.russnes@medisin.uio.no., Lassen U; Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. ulrik.lassen@regionh.dk., Hallersjö Hult E; Stockholm School of Economics Institute for Research, Stockholm, Sweden. ebba.hallersjo.hult@hhs.se., Lugowska I; Maria Sklodowska-Curie Institute of Oncology, Warsaw, Poland. Iwona.Lugowska@nio.gov.pl., Blay JY; Centre Léon Bérard, Lyon, France. jean-yves.blay@lyon.unicancer.fr., Verlingue L; Centre Léon Bérard, Lyon, France. Loic.VERLINGUE@lyon.unicancer.fr., Abel E; Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden; Department of Oncology, Sahlgrenska University Hospital, Gothenburg, Sweden. edvard.abel@vgregion.se., Lowery MA; Trinity St James Cancer Institute, Trinity College, Dublin, Ireland. MLOWERY@tcd.ie., Krebs MG; Division of Cancer Sciences, The University of Manchester and The Christie NHS Foundation Trust, Manchester, UK. matthew.krebs@nhs.net., Staal Rohrberg K; Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. kristoffer.staal.rohrberg@regionh.dk., Ojamaa K; Hematology-Oncology Clinic at Tartu University Hospital, Tartu, Estonia. Kristiina.Ojamaa@kliinikum.ee., Oliveira J; Instituto Português de Oncologia do Porto FG, Porto, Portugal. julio.oliveira@ipoporto.min-saude.pt., Verheul HMW; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. h.verheul@erasmusmc.nl., Voest EE; Department of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands. e.voest@nki.nl., Gelderblom H; Department of Medical Oncology, Leiden University Medical Centre, Leiden, The Netherlands. a.j.gelderblom@lumc.nl.
مؤلفون مشاركون: PRIME-ROSE Consortium and the PCM4EU Consortium
المصدر: Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2024 May 23; Vol. 63, pp. 385-391. Date of Electronic Publication: 2024 May 23.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Medical Journals Sweden AB Country of Publication: Sweden NLM ID: 8709065 Publication Model: Electronic Cited Medium: Internet ISSN: 1651-226X (Electronic) Linking ISSN: 0284186X NLM ISO Abbreviation: Acta Oncol Subsets: MEDLINE
مواضيع طبية MeSH: Precision Medicine*/methods , Neoplasms*/therapy, Humans ; Europe ; European Union ; Drug Repositioning ; Clinical Trials as Topic/organization & administration